Enantioselective synthesis, chiral starting

Enantiomers (Section 7 1) Stereoisomers that are related as an object and its nonsupenmposable mirror image Enantioselective synthesis (Section 27 4) Reaction that converts an achiral or racemic starting material to a chiral product in which one enantiomer is present in excess of the other... 

Methodology for the enantioselective synthesis of a broad range of chiral starting materials, by both chiral catalytic and controller-directed processes, is rapidly becoming an important factor in synthesis. The varied collection of molecules which are accessible by this technology provides another type of chiral S-goal for retrosynthetic analysis. 

The enantioselective synthesis of the V-benzyl-substituted /3-lactam 274a (NR2 = PhCH2NH), a precursor for carbapenem antibiotics, was described starting from the chiral synthon 5(R)-menthyloxy-2(5//)-furanone 170 (Scheme 71)... 

For the performance of an enantioselective synthesis, it is of advantage when an asymmetric catalyst can be employed instead of a chiral reagent or auxiliary in stoichiometric amounts. The valuable enantiomerically pure substance is then required in small amounts only. For the Fleck reaction, catalytically active asymmetric substances have been developed. An illustrative example is the synthesis of the tricyclic compound 17, which represents a versatile synthetic intermediate for the synthesis of diterpenes. Instead of an aryl halide, a trifluoromethanesul-fonic acid arylester (ArOTf) 16 is used as the starting material. With the use of the / -enantiomer of 2,2 -Z7w-(diphenylphosphino)-l,F-binaphthyl ((R)-BINAP) as catalyst, the Heck reaction becomes regio- and face-selective. The reaction occurs preferentially at the trisubstituted double bond b, leading to the tricyclic product 17 with 95% ee. °... 

Enantioselective synthesis (Chapter 19 Focus On) A reaction method that yields only a single enantiomer of a chiral product starting from an achiral substrate. 

Since the addition of dialkylzinc reagents to aldehydes can be performed enantioselectively in the presence of a chiral amino alcohol catalyst, such as (-)-(1S,2/ )-Ar,A -dibutylnorephedrine (see Section 1.3.1.7.1.), this reaction is suitable for the kinetic resolution of racemic aldehydes127 and/or the enantioselective synthesis of optically active alcohols with two stereogenic centers starting from racemic aldehydes128 129. Thus, addition of diethylzinc to racemic 2-phenylpropanal in the presence of (-)-(lS,2/ )-Ar,W-dibutylnorephedrine gave a 75 25 mixture of the diastereomeric alcohols syn-4 and anti-4 with 65% ee and 93% ee, respectively, and 60% total yield. In the case of the syn-diastereomer, the (2.S, 3S)-enantiomer predominated, whereas with the twtf-diastereomer, the (2f ,3S)-enantiomer was formed preferentially. 

Strained molecules such as cyclopropanes and cyclobutanes have emerged as important intermediates in organic synthesis. We have already demonstrated here that cyclobutane derivatives can indeed serve as starting materials for the synthesis of natural as well as unnatural products. Unlike cyclopropanes, which can be prepared asymmetrically in a number of ways 175 -182>, the asymmetric synthesis of cyclobutane derivative has received less attention, and, to our best knowledge, very few reports were recorded recently 183). Obviously, the ready availability of chiral cyclobutane derivatives would greatly enhance their usefulness in the enantioselective synthesis of natural products. The overcome of this last hurdle would allow cyclobutane derivatives to play an even more important role in synthetic organic chemistry. 

In the enantioselective synthesis, the asymmetry (i.e., the stereoselectivity) is induced by the external chiral catalyst, while the diastereoselective synthesis does not require a chiral catalyst. The stereogenic center already present in the molecule is able to induce stereoselectivity, assuming that the synthesis starts with a single enantiomer. For instance, imagine that an a,/ -substituted product is formed, and that the reactant already contains a stereogenic carbon at a. If the reaction of (aS) leads, e.g., largely to (aS, / R) and hardly to the (aS, /IS) diastereomer (i.e., stereoisomers that are not mirror-images of each other), the reaction is diastereoselective (Scheme 14.2). 

Two formal syntheses of (-)- [80] and (+)-kumausallene [81] followed this route and relied on the enantioselective preparation of the 2,6-dioxabicyclo[3.3.0]octane core 69 starting from diethyl tartrate or an appropriate chiral sulfoxide. In contrast, Evans et al. [82] used a distinct biomimetic approach in their enantioselective synthesis of the natural product (-)-62 (Scheme 18.23). 

Other similar lipase/esterase resolution processes have been developed such as the use of Bacillus that esterase to produce the substituted propanoic acids that are precursors of non-steroidal anti-inflammatory drags, snch as naproxen and ibuprofen etc., and the formation of chiral amines by Celgene. Other methods start from prochiral precursors and have the advantage that enantioselective synthesis allows the production of particular isomers in yields approaching 100%, rather than the 50% yields characteristic of resolution processes. For instance Hoechst have patented the production of enantiomers using Pseudomonas fluorescens lipase to either acylate diols or hydrolyse diacetate esters. 

A useful method for the diastereoselective and enantioselective synthesis of trans-and m-l,2-disubstituted cycloalkanecarboxaldehydes was devised by Koga et al.1990 starting from cycloalkanecarboxaldehydes. (S)-/er/.-Leucine ter/.-butyl ester, a highly effective chiral auxiliary reagent, could be recovered for recycling without any loss of optical purity in a reaction sequence similar to that in the acyclic synthesis of (202). 

The enantioselective synthesis of a somewhat more complex renin inhibitor starts with the reduction of the ester group in the chiral amino-ester (19-1) by means of diisobutyl aluminum hydride in the cold. The aldehyde product (19-2) is then reacted with prior isolation with the ylide from phosphonium salt (19-3) and a strong base... 

The cataracts that can appear even in those diabetics whose disease is under control have been attributed to accumulation in the eye of sorbitol that results from the reduction of glucose by elevated levels of the enzyme aldose reductase that accompanies the disease. Inhibitors of that enzyme have been investigated as a means for controlling such cataracts. Known agents, as would be expected with enzyme inhibitors, tend to show marked differences in potency between optical isomers. The enantioselective synthesis of one of these compounds starts with the formation of an imine (12-3) of dihydrochromone (12-1) with the S form of the chiral... 

An alternate approach comprises replacing the pendant sugar by either a carbo-cyclic or a heterocyclic ring. The enantioselective synthesis starts by formation of the imide (45-3) by reaction of the aion from the chiral auxiliary (45-2), derived from S-phenylalaninol and the pentene ester (45-1). Treatment of the product with triethyl amine and the trifalate from dibutylboronic acid leads to the transient enol borate (45-4). Aldol addition of that enol to acrolein proceeds stereospecifically to the alcohol (45-5) due to the transfer of chirality from the chiral auxiliary. 

Isosorbide (3) as a starting material from the chiral pool is the educt for the ten-step enantioselective synthesis 73 of ll-deoxy-8-epi-ll-oxaprosta-glandin (150a) and its (15/ ) diastereoisomer (150b) (see Scheme 42). (/ ,/ J-cw-2,6-Dioxabicyclo[3.3.0]octane (115) was the starting compound ... 

Enantioselective synthesis of analogous p-lactams has been also reported [63]. If the starting imine complex was prepared from the corresponding chiral amine in enantiomerically pure form (Fig. 1), two separable diastereomers were obtained. Using, then, one of the two diastereomers, ck-p-lactams were isolated as single enantiomers. 

The first enantioselective polyene tetracydization starting with a chiral epoxide was reported by Corey et al. in 1997 [8a]. The silylated enol ether 3 (Scheme 1) was converted into the tetracycle 4 by treatment with the Lewis acid MeAlCl2 at -90 °C. The synthetic route is modeled on the biosynthesis of lanosterol from (3S)-squalene 2,3-epoxide and has also been applied to the biomimetic synthesis of tetracyclic polyprenoids from sediment bacteria [8b]. 

---